Gene Editing Market: Growth, Size, Share, and Trends

Report Code BT 3380
Published in Nov, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (gRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-In), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) - Global Forecast to 2029

Market Growth Outlook Summary

The global gene editing market, valued at US$4.44 billion in 2023, is forecasted to grow at a robust CAGR of 10.2%, reaching US$4.66 billion in 2024 and an impressive US$7.59 billion by 2029. Market growth is attributed to factors such as advancements in gene editing technologies, the expanding range of gene editing applications, rising demand for personalized medicine, and the growing prevalence of congenital disorders. However, the market faces several challenges, including off-target effects of gene editing and issues with scalability and manufacturing, which pose significant hurdles.

Gene Editing Market – Global Forecast and Key Opportunities to 2029

North America

Growth in the North American gene editing market can be attributed the surge in development and approval of advanced therapies requiring gene editing products and services.

The expanding scope of gene editing applications, compounded by introduction of new technologies such as bridge RNA and prime editing along with rising government funding and support to gene editing research is driving the market

Expanding pipeline candidates which utilize gene editing for manufacture and increased demand for personalized medicine along with rise in global infant and congenital disorders present significant growth opportunities for this market

Off Target effects, along with high equipment and facility costs can limit the growth of this market.

Globally, North America is the largest market for gene editing and this trend is expected to continue during the forecast period.

Gene Editing Market Dynamics to 2029

DRIVER: Expanding scope of gene editing applications

Cell and gene therapies are advanced therapies used to treat a wide range of diseases such as cancer, cystic fibrosis, heart disease, and genetic disorders. Cell therapy is referred to a therapy in which viable cells are injected or implanted into patient’s body to get therapeutic effects. On the other hand, gene therapy is the medical technology used to produce therapeutic effect through manipulation of gene expressions. Thus, cell and gene therapies are widely used for the treatment of genetic and rare diseases. The adoption of cell & gene therapy has increased over the last few years, and this trend is expected to continue in the coming years due to the high and rising incidence of cancer and other rare diseases. For instance, to data released by GLOBOCAN in 2020, it was estimated that 19.3 million cases new cancer cases and 10.0 million cancer deaths occurred in 2020. The global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020. Therefore, increasing need of cell & gene therapy due to rising prevalence of chronic diseases is propelling the growth of transfection technologies market.

RESTRAINT: Off-target effects and safety concerns.

Off-target effects and safety concerns limit gene editing market expansion. Despite its precision in gene editing, CRISPR-Cas9 encounters off-target DNA cleavage effects. The single-guide RNA (sgRNA) can guide the Cas9 enzyme to splice DNA at mistargeted locations in the genome. Such effects can cause non-specific and hazardous gene modifications, reducing gene editing's therapeutic application. Many methods have been developed to decrease off-target effects, including sgRNA optimization, Cas9 nuclease modifications, and prime editors. These advancements are not failsafe, and off-target consequences remain a concern, especially in precision-driven therapeutics. The safety of gene editing extends beyond the patient to laboratory and clinical workers and close contacts. The use of viral vectors like adeno-associated viruses (AAVs) for gene delivery requires strict safety precautions to avoid genome integration or infection. Another ethical and safety issue is germline editing, which could affect future generations. These factors make the market cautious, restricting gene editing technology adoption until these hazards are known and managed.

 

OPPORTUNITY: Technological advancements in Prime editing and bridge RNA

New directions in gene editing are being opened by advancements such prime editing and bridge RNA technologies, which offer more exact and effective solutions. Combining Cas9 with reverse transcriptase and prime editing guide RNA improves accuracy by means of a modification of the CRISPR-Cas9 system, thus permitting repair of single base mutations and DNA insertions without double-stranded breaks, so minimizing off-target effects. Research by AstraZeneca in March 2022 revealed the promise of prime editing for exact DNA insertions with low deletions. Targeting rare immunodeficiency, chronic granulomatosis disease (CGD), Prime Medicine's candidate PM3Sg was approved by the FDA for Phase I/II trials.

Another approach is Bridge RNA, which minimizes collateral damage by joining target DNA with desired sequences thereby enabling large-scale DNA modifications in one stroke. The Broad Institute showed in June 2024 that bridge RNA could insert sizable DNA fragments into human cells, hence enhancing gene-editing precision. These developments improve the safety and accuracy of gene editing, hence increasing the therapeutic possibilities. New directions in gene editing are being opened by advancements such prime editing and bridge RNA technologies, which offer more exact and effective solutions. Combining Cas9 with reverse transcriptase and prime editing guide RNA improves accuracy by means of a modification of the CRISPR-Cas9 system, thus permitting repair of single base mutations and DNA insertions without double-stranded breaks, so minimizing off-target effects. Research by AstraZeneca in March 2022 revealed the promise of prime editing for exact DNA insertions with low deletions. Targeting rare immunodeficiency, chronic granulomatosis disease (CGD), Prime Medicine's candidate PM3Sg got FDA permission for Phase I/II trials.

CHALLENGES: Issues with scalability of gene editing workflows

Gene editing workflow scalability and manufacturing challenges limit market growth. Gene editing workflows like ex vivo approaches, are intricate and expensive. This complexity is aggravated by the difficulties of expanding operations from clinical and experimental use with few applications to bigger commercial uses. Demand for raw materials has caused significant shortages for manufacturing slots at CDMOs & CROs. Sponsors have encountered 18–24-month delays, slowing gene editing program progress. Some larger biopharmaceutical businesses have invested in their own production facilities to manage their supply chains, which smaller biotech firms are unable to accomplish. These start-ups rely on external vendors, which can limit their output and cost control. Scaling up production is difficult since it requires balancing therapeutic efficacy, toxicity, and immunogenicity. Despite advances in delivery technology, viral vectors such as rAAV are preferred because of their ability to transduce a large number of cells and low immunogenicity. The rising demand for rAAV vectors and their production complexity continue to challenge the gene editing market, potentially slowing the transition from clinical trials and research to widespread commercial application.

Gene Editing Market Map & Ecosystem Overview

The gene editing market ecosystem encompasses product, service, end user, and regulatory authorities. Gene Editing Product Providers create kits, reagents, software, and technologies like CRISPR and TALENs for gene editing. Gene Editing Service Providers provide unique gene editing, consulting, and technical assistance to clients who need customized solutions or lack in-house knowledge. Academic institutions, biotechnology, and pharmaceutical companies, and CROs use gene editing technologies and services for drug discovery, gene therapy development, and agricultural biotechnology. Their actions drive gene editing product and service demand. Gene editing products and services must meet safety, effectiveness, and ethical requirements set by regulators. These bodies regulate gene editing technology research and use, particularly in clinical and therapeutic settings. The gene editing market ecosystem is shaped by product, service, end user, and regulatory interactions.

 

The CRISPR segment accounted for the largest share of the product technology segment of the gene editing market in 2023.

The gene editing market is segmented into CRISPR, TALEN, ZFN, Base editing, Antisense, RNAi and other technologies which include Piggybac, Prime editing among others. The CRISPR segment held the highest share of the gene editing products market by technology driven by advancements in CRISPR technology, products cater to a range of CRISPR applications, from gene knockout to precise gene correction or insertions using tools like donor oligos and design software for CRISPR-based genome editing. However, TALEN held the second highest share of the gene editing market. The gene editing products market for CRISPR technologies is expanding, with various companies offering a variety of tools and reagents. Cas9 proteins are vital products, with variants like wild-type, enhanced specificity, nickase, and GFP-fused versions available. Merck KGaA (Germany) offers Cas9 proteins and CRISPR activation and inhibition libraries, while Integrated DNA Technologies, Inc. (US) provides guide RNAs and Alt-R HDR donor oligos for homology-directed repair (HDR) experiments. Takara Bio Inc. (Japan) supplies CRISPR kits like the Guide-it sgRNA in vitro transcription kit. Revvity, Inc. (US) offers genome-wide CRISPR screening libraries.

The pharmaceutical & biotechnology segment accounted for the largest share of the services end user segment of the gene editing market in 2023.

By services end user, the gene editing market is segmented into pharmaceutical & biotechnology companies, Academic & research institutes, and other end users which include diagnostic companies, biobanks, and small-scale CDMOs among others. Pharmaceutical & biotechnology companies held the highest share of the market as they utilize various types of services such as cell line development and engineering, gRNA synthesis & vector construction, and Library construction and screening for various applications such as drug discovery and development. However Academic and research institutes held the second highest share of the gene editing services by end user. Pharmaceutical & biotechnology companies are the key end users of the gene editing services market as these firms utilize services such as cell line development & engineering, gRNA synthesis & vector construction, and library construction and screening for drug discovery and development. For instance, in June 2024, Revvity, Inc. (US) collaborated with GenKOre (South Korea) to develop gene therapies for ocular disorders using Revvity’s AAV vectors. Revvity, Inc. also collaborated with AstraZeneca plc (UK) to use Revvity’s gene editing services for drug development in May 2023. The utilization of library construction & screening services to create in-house platform technologies for research & target identification is vital. For Instance, in February 2023, Tecan Life Sciences (UK) collaborated with Singular Genomics (US) to create libraries for the G4 Sequencing platform

The North American region accounted for the largest share of the gene editing market in 2023.

The gene editing market is segmented into six major regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America is the largest regional market for gene editing in 2023, while Europe is the second-largest market. The large share of North America can be attributed to the surge in development and approval of advanced therapies requiring gene editing products and services. However, The Asia Pacific is estimated to be the fastest-growing segment of the market characterized by a significant focus on R&D activities to broaden the scope of genomics applications, increasing adoption of genomics technologies for diagnostics, and technological developments in genomic data analysis. The gene editing market in the United States is distinguished by a collaborative environment, strong government support, major investment, and R&D initiatives. The US National Institutes of Health (NIH) has been a key driver, investing USD 814 million in gene editing projects as of September 2024, including the Somatic Cell Genome Editing (SCGE) program, which received more than USD 140 million in funding in July 2023 to accelerate genome editing from lab research to clinical applications. Furthermore, the NIH will provide USD 22 million to UC Berkeley and Ohio State University in July 2023 to explore CRISPR-based therapeutics for neurological illnesses, demonstrating the government's commitment to promoting research.

HIGHEST CAGR MARKET IN 2024
US FASTEST GROWING MARKET IN THE REGION

Gene Editing Market Recent Developments and Insights

  • In July 2024, Agilent Technologies, Inc. (US) acquired BIOVECTRA, Inc. (Canada), enhancing its biopharma solutions with BIOVECTRA’s expertise in biologics and gene editing. The acquisition expanded Agilent’s capabilities in drug development and manufacturing.
  • In June 2024, GenKOre (South Korea) and Revvity (US) collaborated to develop gene therapies for ocular disorders using GenKOre's TaRGET platform and Revvity's AAV vectors. The partnership aimed to advance in vivo gene-editing therapies for Leber Congenital Amaurosis 10 and Usher Syndrome Type 2A, potentially leading to expanded development and commercialization opportunities.
  • In May 2024, Merck KGaA (Germany), acquired Mirus Bio, Inc. (US), integrating Mirus Bio's transfection technology with Merck's bioprocessing expertise. This acquisition, completed enhanced Merck’s capabilities in viral vector manufacturing, advancing support for cell and gene therapies.
  • In March 2023, GenScript (US) announced a strategic collaboration with PersonGen-Anke Cellular Therapeutics (US) to advance cell isolation products. This partnership aimed to enhance cell therapy development and production efficiency. GenScript's CytoSinct platform was expected to support PersonGen in reducing costs and improving R&D efficiency in cell therapy.

Gene Editing Market – Leading Key Players Analysis

KEY PLAYERS IN THE GENE EDITING MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Gene Editing Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD Million)
Segments covered Offerings, Products by Type, Reagents & Consumables by Technique, Products by Technology, Products by Application, Products by End User, Services by Type, Services By Application, Services by End User.
Geographies covered North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

Key Questions Addressed by the Report

The global gene editing market is projected to grow from USD 4.66 billion in 2024 to USD 7.59 billion by 2029, demonstrating a robust CAGR of 10.2%.
The major factors driving market growth include technological advancements in gene editing tools like CRISPR, TALEN, and ZFN, increased demand for personalized medicine, and government investments supporting gene editing research. Additionally, the growing burden of genetic disorders and the potential of gene-based therapies further fuel the market's expansion.
CRISPR technology holds the largest share of the gene editing market due to its high precision and efficiency in gene modification. It is widely used in various applications, including gene knockout, gene correction, and genome editing.
The cell line engineering application segment holds the largest share in the gene editing market. The demand for precise cell line development for drug discovery, genetic research, and therapeutic applications contributes to this growth.
North America leads the gene editing market due to the high concentration of research institutions, strong government support, and advancements in gene-based therapies. Europe follows as the second-largest market, with substantial investments in biotechnology and gene editing research.
Prime editing and base editing are expected to witness the highest growth in the gene editing market. These technologies offer higher precision and fewer off-target effects compared to traditional methods like CRISPR and TALEN, making them increasingly popular for genetic modifications.
Key players in the gene editing market include Thermo Fisher Scientific Inc., Merck KGaA, GenScript, Agilent Technologies, and Revvity. These companies are adopting organic and inorganic growth strategies such as acquisitions, partnerships, and new product developments to strengthen their market positions.

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Gene Editing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
43
RESEARCH METHODOLOGY
48
EXECUTIVE SUMMARY
60
PREMIUM INSIGHTS
66
MARKET OVERVIEW
68
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing demand for personalized medicine
    - Favorable government funding investments for gene editing projects
    - Expanding applications of gene editing
    RESTRAINTS
    - Off-target effects and safety concerns
    OPPORTUNITIES
    - Rising technological advancements in prime editing and bridge RNA
    - Increasing burden of congenital disorders
    CHALLENGES
    - Issues associated with scalability of gene editing workflows
    - High equipment & manufacturing costs
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.4 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY CONSUMABLE (2023)
    AVERAGE COST RANGE OF GENE EDITING KITS & REAGENTS, 2021−2023
    AVERAGE SELLING PRICE TREND OF SERVICES, BY TYPE
    AVERAGE SELLING PRICE, BY REGION
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 IMPACT OF GENERATIVE AI ON GENE EDITING MARKET
  • 5.9 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Next-generation sequencing
    - Electroporation
    - Microinjection
    COMPLEMENTARY TECHNOLOGIES
    - Synthetic biology
    - Data analysis
    - High-throughput screening
    ADJACENT TECHNOLOGIES
    - Single-cell analysis
    - Optogenetics
    - Gene delivery systems
  • 5.10 PATENT ANALYSIS
  • 5.11 KEY CONFERENCES AND EVENTS, 2024−2025
  • 5.12 REGULATORY ANALYSIS
    REGULATORY LANDSCAPE
    - North America
    - Europe
    - Asia Pacific
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.13 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.15 CASE STUDY ANALYSIS
    ENHANCED GENE KNOCK-IN EFFICIENCY USING HYBRID SSDNA HDR TEMPLATES IN PRIMARY HUMAN T-CELLS
    GENE EDITING EFFICIENCY IN CANCER CELL LINES AND T-CELLS USING TRUECUT CAS9 PROTEIN V2 AND TRUEGUIDE SGRNA
    DEVELOPMENT & SPECIFICITY OPTIMIZATION OF PUREDIT CRISPR CAS9 RNP SYSTEM
    EVALUATION OF SUREGUIDE CAS9 PROGRAMMABLE NUCLEASE KIT FOR EFFICIENT IN VITRO GENE EDITING
    GENE EDITING FOR SICKLE-CELL DISEASE USING ZINC FINGER NUCLEASE-MODIFIED HEMATOPOIETIC STEM CELLS
  • 5.16 INVESTMENT & FUNDING SCENARIO
    KEY INVESTMENTS & FUNDING ACTIVITIES, 2021−2024
  • 5.17 TRADE DATA ANALYSIS
    IMPORT DATA, 2019−2023
    EXPORT DATA, 2019−2023
GENE EDITING MARKET, BY OFFERING
112
  • 6.1 INTRODUCTION
  • 6.2 PRODUCTS
    EXPANDING APPLICATIONS OF GENE MODIFICATION TECHNIQUES TO DRIVE MARKET
  • 6.3 SERVICES
    HIGH UPTAKE BY PHARMA COMPANIES FOR DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET
GENE EDITING PRODUCTS MARKET, BY TYPE
121
  • 7.1 INTRODUCTION
  • 7.2 REAGENTS & CONSUMABLES
    GENE EDITING KITS
    - Increasing demand for mutation & screening kits in clinical settings to propel market
    GENE EDITING LIBRARIES
    - Genetic screening for cancer research to fuel uptake
    GENE EDITING REAGENTS
    - Ability to create animal models to support market growth
  • 7.3 SOFTWARE & SYSTEMS
    INTEGRATION OF CLOUD-BASED PLATFORMS FOR NGS TO DRIVE MARKET
GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE
141
  • 8.1 INTRODUCTION
  • 8.2 KNOCK-OUT
    MODIFICATION OF CRISPR-CAS9 AND TALENS TO PROPEL MARKET
  • 8.3 KNOCK-IN
    UTILIZATION OF DONOR DNA TEMPLATES AND HDR PATHWAYS TO DRIVE MARKET
  • 8.4 GENE SILENCING
    ADVANCEMENTS IN RNAI TECHNOLOGY AND ANTISENSE THERAPY TO SUPPORT MARKET GROWTH
  • 8.5 OTHER TECHNIQUES
GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY
156
  • 9.1 INTRODUCTION
  • 9.2 CRISPR
    ADVANCEMENTS IN CAS9 PROTEINS TO FUEL UPTAKE
  • 9.3 TALENS
    INCREASING DEMAND FOR THERAPEUTIC DEVELOPMENT TO DRIVE MARKET
  • 9.4 ZFN
    PROVISION OF CUSTOMIZED DESIGN AND TARGETED EDITS TO BOOST DEMAND
  • 9.5 BASE EDITING
    GROWING APPLICATIONS IN FUNCTIONAL GENOMICS TO FUEL MARKET
  • 9.6 ANTISENSE
    INNOVATIONS IN OLIGONUCLEOTIDE THERAPIES TO SUPPORT MARKET GROWTH
  • 9.7 RNAI
    WIDE APPLICATIONS IN DRUG DISCOVERY TO FUEL UPTAKE
  • 9.8 OTHER TECHNOLOGIES
    GENE EDITING PRODUCTS MARKET, BY APPLICATION
GENE EDITING PRODUCTS MARKET, BY APPLICATION
180
  • 10.1 INTRODUCTION
  • 10.2 CELL LINE ENGINEERING
    ABILITY TO PROVIDE PRECISE GENE MODIFICATIONS FOR VALIDATION TO DRIVE MARKET
  • 10.3 GENOME EDITING
    GROWING APPLICATIONS IN BIOTECHNOLOGY TO BOOST DEMAND
  • 10.4 DRUG DISCOVERY & DEVELOPMENT
    UPTAKE OF CRISPR-BASED SYSTEMS FOR DISEASE PROFILING TO DRIVE MARKET
  • 10.5 OTHER APPLICATIONS
GENE EDITING PRODUCTS MARKET, BY END USER
195
  • 11.1 INTRODUCTION
  • 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    INCREASING PRODUCT APPROVALS AND ROBUST CLINICAL PIPELINE TO PROPEL MARKET
  • 11.3 ACADEMIC & RESEARCH INSTITUTES
    FAVORABLE FUNDING FOR GENOMIC PROJECTS TO DRIVE MARKET
  • 11.4 CROS & CDMOS
    PROVISION OF SPECIALIZED EXPERTISE FOR CLINICAL TRIALS TO DRIVE MARKET
  • 11.5 OTHER END USERS
GENE EDITING SERVICES MARKET, BY TYPE
210
  • 12.1 INTRODUCTION
  • 12.2 CELL LINE DEVELOPMENT & ENGINEERING
    GROWING DEMAND FOR BIOLOGICS AND BIOSIMILARS TO DRIVE MARKET
  • 12.3 GRNA SYNTHESIS & VECTOR CONSTRUCTION
    ADVANCEMENTS IN GENE EDITING TECHNOLOGIES AND DEMAND FOR PRECISE TARGETING TO DRIVE MARKET
  • 12.4 LIBRARY CONSTRUCTION & SCREENING
    INCREASING FOCUS ON HIGH-THROUGHPUT SCREENING TO PROPEL MARKET
  • 12.5 OTHER SERVICES
    OTHER SERVICES INCLUDE OFF-TARGET ANALYSIS AND MUTAGENESIS SERVICES.
GENE EDITING SERVICES MARKET, BY APPLICATION
226
  • 13.1 INTRODUCTION
  • 13.2 CELL LINE ENGINEERING
    HIGH UPTAKE IN R&D FOR THERAPEUTIC BIOPRODUCTION TO DRIVE MARKET
  • 13.3 GENOME EDITING
    GROWING FOCUS ON SYNTHETIC GENOMICS TO BOOST DEMAND
  • 13.4 DRUG DISCOVERY & DEVELOPMENT
    GROWING DEMAND FOR PHARMACEUTICAL DEVELOPMENT TO FUEL UPTAKE
  • 13.5 OTHER APPLICATIONS
GENE EDITING SERVICES MARKET, BY END USER
242
  • 14.1 INTRODUCTION
  • 14.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    GROWING DEMAND FOR ADVANCED MODALITIES TO DRIVE MARKET
  • 14.3 ACADEMIC & RESEARCH INSTITUTES
    INCREASING FUNDING FOR GENOMIC PROJECTS TO PROPEL MARKET
  • 14.4 OTHER END USERS
GENE EDITING MARKET, BY REGION
254
  • 15.1 INTRODUCTION
  • 15.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Growing investments by government authorities and private players to drive market
    CANADA
    - Rise in research & development initiatives for genomics and biotechnology to augment growth
  • 15.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Growing focus on promoting innovations in biotechnology sector to boost market
    FRANCE
    - Ongoing clinical trials and advanced genomic research to promote growth
    UK
    - Growing focus on developing cell and gene therapy infrastructure to fuel market
    ITALY
    - Increasing availability of research funds to expedite growth
    SPAIN
    - Booming biotechnology sector to contribute to market growth
    REST OF EUROPE
  • 15.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Increasing affordability of sequencing platforms and procedures to favor growth
    JAPAN
    - Growing focus on cancer research to fuel market
    INDIA
    - Increased awareness about therapeutic benefits of genome engineering to encourage growth
    SOUTH KOREA
    - Rising inclination toward in vivo gene editing to stimulate growth
    AUSTRALIA
    - Favorable regulatory landscape to sustain growth
    REST OF ASIA PACIFIC
  • 15.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Supportive regulatory framework for biotechnology innovation to fuel market
    REST OF LATIN AMERICA
  • 15.6 MIDDLE EAST
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST
    GCC COUNTRIES
    - Kingdom of Saudi Arabia
    - United Arab Emirates (UAE)
    - Other GCC Countries
    REST OF MIDDLE EAST
  • 15.7 AFRICA
    IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
    MACROECONOMIC OUTLOOK FOR AFRICA
COMPETITIVE LANDSCAPE
388
  • 16.1 INTRODUCTION
  • 16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021−2024
  • 16.3 REVENUE ANALYSIS, 2019−2023
  • 16.4 MARKET SHARE ANALYSIS, 2023
    RANKING OF KEY MARKET PLAYERS
  • 16.5 COMPANY VALUATION AND FINANCIAL METRICS
    COMPANY VALUATION
    FINANCIAL METRICS
  • 16.6 BRAND/PRODUCT COMPARISON
    THERMO FISHER SCIENTIFIC INC. (US)
    MERCK KGAA (GERMANY)
    GENSCRIPT (US)
    AGILENT TECHNOLOGIES, INC. (US)
    REVVITY, INC. (US)
  • 16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Product footprint
    - Service footprint
    - Technology footprint
    - Region footprint
  • 16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 16.9 COMPETITIVE SCENARIO
    PRODUCT/SERVICE LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
COMPANY PROFILES
414
  • 17.1 KEY PLAYERS
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    GENSCRIPT
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    REVVITY, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    LONZA
    - Business overview
    - Products/Services offered
    - Recent developments
    TECAN TRADING AG
    - Business overview
    - Products/Services offered
    - Recent developments
    SANGAMO THERAPEUTICS
    - Business overview
    - Products/Services offered
    - Recent developments
    PRECISION BIOSCIENCES
    - Business overview
    - Products/Services offered
    - Recent developments
    CELLECTIS S.A.
    - Business overview
    - Products/Services offered
    - Recent developments
    REGENERON PHARMACEUTICALS, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    AMSBIO
    - Business overview
    - Products/Services offered
    CREATIVE BIOGENE
    - Business overview
    - Products/Services offered
    SYNTHEGO
    - Business overview
    - Products/Services offered
    - Recent developments
    TAKARA BIO INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    BIO-TECHNE
    - Business overview
    - Products/Services offered
    - Recent developments
    CARIBOU BIOSCIENCES, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    BIONEER CORPORATION
    - Business overview
    - Products/Services offered
    REPROCELL INC.
    - Business overview
    - Products/Services offered
  • 17.2 OTHER PLAYERS
    ALSTEM INC.
    NEW ENGLAND BIOLABS
    INSCRIPTA, INC.
    BIOCAT GMBH.
    INTEGRATED DNA TECHNOLOGIES, INC.
    COBO TECHNOLOGIES APS
    GENECOPOEIA, INC.
    HERA BIOLABS
    STEMCELL TECHNOLOGIES.
    AXOL BIOSCIENCE LTD.
    CELLECTA, INC.
    APPLIED STEMCELL
APPENDIX
489
  • 18.1 DISCUSSION GUIDE
  • 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 18.3 CUSTOMIZATION OPTIONS
  • 18.4 RELATED REPORTS
  • 18.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 2 GENE EDITING MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 GENE EDITING MARKET: IMPACT ANALYSIS
  • TABLE 4 APPROVALS FOR PERSONALIZED MEDICINE (GENE THERAPIES), 2023−2024
  • TABLE 5 PERSONALIZED MEDICINE APPROVALS (GENE THERAPIES) IN 2022
  • TABLE 6 AVERAGE COST RANGE OF GENE EDITING KITS & REAGENTS, 2021−2023
  • TABLE 7 AVERAGE SELLING PRICE, BY REGION, 2021−2023 (USD)
  • TABLE 8 COMMERCIALIZATION OF AI IN GENE EDITING
  • TABLE 9 GENE EDITING MARKET: KEY CONFERENCES & EVENTS, 2024–2025
  • TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 GENE EDITING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 15 GENE EDITING MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
  • TABLE 16 INVESTMENT & FUNDING ACTIVITIES, BY KEY PLAYER (2021−2024)
  • TABLE 17 IMPORT DATA FOR KITS & REAGENTS, BY REGION, 2019−2023 (USD)
  • TABLE 18 EXPORT DATA FOR KITS & REAGENTS, BY REGION, 2019−2023 (USD THOUSAND)
  • TABLE 19 GENE EDITING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 20 GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 21 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 22 EUROPE: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 23 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 24 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 25 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 26 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 27 GENE EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 28 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 29 EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 33 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 35 GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 36 GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 37 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 EUROPE: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 42 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 GENE EDITING KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA: GENE EDITING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 45 EUROPE: GENE EDITING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: GENE EDITING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 LATIN AMERICA: GENE EDITING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 MIDDLE EAST: GENE EDITING KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 49 GCC COUNTRIES: GENE EDITING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 50 GENE EDITING LIBRARIES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 51 NORTH AMERICA: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 EUROPE: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 ASIA PACIFIC: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 LATIN AMERICA: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 MIDDLE EAST: GENE EDITING LIBRARIES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 56 GCC COUNTRIES: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 GENE EDITING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 EUROPE: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 61 LATIN AMERICA: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 MIDDLE EAST: GENE EDITING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 63 GCC COUNTRIES: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 EUROPE: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 70 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 72 KNOCK-OUT TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 73 NORTH AMERICA: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 EUROPE: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 76 LATIN AMERICA: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 MIDDLE EAST: KNOCK-OUT TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 78 GCC COUNTRIES: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 KNOCK-IN TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 81 EUROPE: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 83 LATIN AMERICA: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 MIDDLE EAST: KNOCK-IN TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 85 GCC COUNTRIES: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 GENE SILENCING TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 87 NORTH AMERICA: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 88 EUROPE: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 89 ASIA PACIFIC: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 90 LATIN AMERICA: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 MIDDLE EAST: GENE SILENCING TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 92 GCC COUNTRIES: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 93 OTHER TECHNIQUES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 EUROPE: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 97 LATIN AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 98 MIDDLE EAST: OTHER TECHNIQUES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 99 GCC COUNTRIES: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 100 GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 101 GENE EDITING PRODUCTS MARKET FOR CRISPR, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 102 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 EUROPE: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 107 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 108 GENE EDITING PRODUCTS MARKET FOR TALEN, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 109 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 110 EUROPE: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 111 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR TALEN, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 114 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 GENE EDITING PRODUCTS MARKET FOR ZFN, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 116 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 EUROPE: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 119 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 120 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ZFN, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 121 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 124 EUROPE: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 126 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 127 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 128 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 129 GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 131 EUROPE: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 134 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 135 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 GENE EDITING PRODUCTS MARKET FOR RNAI, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 137 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 EUROPE: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 140 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 141 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR RNAI, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 142 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 144 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 145 EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 147 LATIN AMERICA: GENE EDITING GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 148 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 149 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 150 GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 151 CELL LINE ENGINEERING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 152 NORTH AMERICA: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 153 EUROPE: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 155 LATIN AMERICA: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 156 MIDDLE EAST: CELL LINE ENGINEERING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 157 GCC COUNTRIES: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 158 GENOME EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 159 NORTH AMERICA: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 160 EUROPE: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 162 LATIN AMERICA: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 163 MIDDLE EAST: GENOME EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 164 GCC COUNTRIES: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 165 DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 166 NORTH AMERICA: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 167 EUROPE: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 169 LATIN AMERICA: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 170 MIDDLE EAST: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 171 GCC COUNTRIES: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) (USD MILLION)
  • TABLE 172 GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 173 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 174 EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 175 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 176 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 177 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 178 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 179 GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 180 GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 181 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 182 EUROPE: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 183 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 184 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 185 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 186 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 187 GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 188 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 189 EUROPE: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 190 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 191 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 192 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 193 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 194 GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 195 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 196 EUROPE: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 197 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 198 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 199 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 200 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 201 GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 202 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 203 EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 204 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 205 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 206 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 207 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 208 GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 209 CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 210 NORTH AMERICA: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 211 EUROPE: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 213 LATIN AMERICA: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 214 MIDDLE EAST: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 215 GCC COUNTRIES: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 216 GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 217 NORTH AMERICA: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 218 EUROPE: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 220 LATIN AMERICA: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 221 MIDDLE EAST: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 222 GCC COUNTRIES: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 223 LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 224 NORTH AMERICA: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 225 EUROPE: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 226 ASIA PACIFIC: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 227 LATIN AMERICA: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 228 MIDDLE EAST: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 230 GENE EDITING MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 231 NORTH AMERICA: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 232 EUROPE: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 233 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 234 LATIN AMERICA: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 235 MIDDLE EAST: GENE EDITING MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 236 GCC COUNTRIES: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 237 GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 238 CELL ENGINEERING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 239 NORTH AMERICA: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 240 EUROPE: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 241 ASIA PACIFIC: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 242 LATIN AMERICA: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 243 MIDDLE EAST: CELL ENGINEERING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 244 GCC COUNTRIES: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 245 GENOME EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 246 NORTH AMERICA: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 247 EUROPE: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 248 ASIA PACIFIC: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 249 LATIN AMERICA: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 250 MIDDLE EAST: GENOME EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 251 GCC COUNTRIES: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 252 DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 253 NORTH AMERICA: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 254 EUROPE: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 255 ASIA PACIFIC: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 256 LATIN AMERICA: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 257 MIDDLE EAST: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 258 GCC COUNTRIES: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 259 GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 260 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 261 EUROPE: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 262 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 263 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 264 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 265 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 266 GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 267 GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 268 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 269 EUROPE: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 270 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 271 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 272 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 273 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 274 GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 275 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 276 EUROPE: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 277 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 278 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 279 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 280 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 281 GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 282 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 283 EUROPE: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 284 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 285 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 286 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 287 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 288 GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 289 GENE EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 290 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 291 NORTH AMERICA GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 292 NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 293 NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 294 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 295 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 296 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 297 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 298 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 299 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 300 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 301 US: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 302 US: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 303 US: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 304 US: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 305 US: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 306 US: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 307 US: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 308 US: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 309 US: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 310 CANADA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 311 CANADA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 312 CANADA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 313 CANADA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 314 CANADA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 315 CANADA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 316 CANADA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 317 CANADA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 318 CANADA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 319 EUROPE: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 320 EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 321 EUROPE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 322 EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 323 EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 324 EUROPE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 325 EUROPE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 326 EUROPE: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 327 EUROPE: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 328 EUROPE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 329 EUROPE: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 330 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 331 GERMANY: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 332 GERMANY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 333 GERMANY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 334 GERMANY: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 335 GERMANY: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 336 GERMANY: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 337 GERMANY: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 338 GERMANY: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 339 GERMANY: GENE EDITING SERVICES MARKET, BY END USERS, 2022–2029 (USD MILLION)
  • TABLE 340 FRANCE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 341 FRANCE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 342 FRANCE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 343 FRANCE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 344 FRANCE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 345 FRANCE: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 346 FRANCE: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 347 FRANCE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 348 FRANCE: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 349 UK: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 350 UK: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 351 UK: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 352 UK: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 353 UK: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 354 UK: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 355 UK: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 356 UK: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 357 UK: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 358 ITALY: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 359 ITALY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 360 ITALY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 361 ITALY: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 362 ITALY: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 363 ITALY: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 364 ITALY: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 365 ITALY: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 366 ITALY: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 367 SPAIN: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 368 SPAIN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 369 SPAIN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 370 SPAIN: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 371 SPAIN: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 372 SPAIN: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 373 SPAIN: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 374 SPAIN: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 375 SPAIN: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 376 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 377 REST OF EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 378 REST OF EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 379 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 380 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 381 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 382 REST OF EUROPE: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 383 REST OF EUROPE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 384 REST OF EUROPE: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 385 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 386 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 387 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 388 ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 389 ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 390 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 391 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 392 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 393 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 394 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 395 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 396 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 397 CHINA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 398 CHINA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 399 CHINA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 400 CHINA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 401 CHINA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 402 CHINA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 403 CHINA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 404 CHINA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 405 CHINA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 406 JAPAN: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 407 JAPAN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 408 JAPAN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 409 JAPAN: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 410 JAPAN: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 411 JAPAN: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 412 JAPAN: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 413 JAPAN: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 414 JAPAN: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 415 INDIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 416 INDIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 417 INDIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 418 INDIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 419 INDIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 420 INDIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 421 INDIA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 422 INDIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 423 INDIA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 424 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 425 SOUTH KOREA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 426 SOUTH KOREA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 427 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 428 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 429 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 430 SOUTH KOREA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 431 SOUTH KOREA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 432 SOUTH KOREA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 433 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 434 AUSTRALIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 435 AUSTRALIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 436 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 437 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 438 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 439 AUSTRALIA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 440 AUSTRALIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 441 AUSTRALIA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 442 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 443 REST OF ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 444 REST OF ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 445 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 446 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 447 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 448 REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 449 REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 450 REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 451 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 452 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 453 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 454 LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 455 LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 456 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 457 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 458 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 459 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 460 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 461 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 462 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 463 BRAZIL: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 464 BRAZIL: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 465 BRAZIL: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 466 BRAZIL: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 467 BRAZIL: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 468 BRAZIL: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 469 BRAZIL: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 470 BRAZIL: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 471 BRAZIL: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 472 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 473 REST OF LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 474 REST OF LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 475 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 476 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 477 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 478 REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 479 REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 480 REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 481 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 482 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 483 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 484 MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 485 MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 486 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 487 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 488 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 489 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 490 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 491 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 492 MIDDLE EAST: MACROECONOMIC INDICATORS
  • TABLE 493 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 494 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 495 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 496 GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 497 GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 498 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 499 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 500 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 501 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 502 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 503 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 504 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 505 KINGDOM OF SAUDI ARABIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 506 KINGDOM OF SAUDI ARABIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 507 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 508 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 509 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 510 KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 511 KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 512 KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 513 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 514 UNITED ARAB EMIRATES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 515 UNITED ARAB EMIRATES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 516 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 517 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 518 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 519 UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 520 UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 521 UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 522 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 523 OTHER GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 524 OTHER GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 525 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 526 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 527 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 528 OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 529 OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 530 OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 531 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 532 REST OF MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 533 REST OF MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 534 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 535 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 536 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 537 REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 538 REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 539 REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 540 AFRICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 541 AFRICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 542 AFRICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 543 AFRICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 544 AFRICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 545 AFRICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 546 AFRICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 547 AFRICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 548 AFRICA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 549 MACROECONOMIC OUTLOOK FOR AFRICA
  • TABLE 550 GENE EDITING MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021−2024
  • TABLE 551 GENE EDITING MARKET: DEGREE OF COMPETITION, 2023
  • TABLE 552 GENE EDITING MARKET: PRODUCT FOOTPRINT
  • TABLE 553 GENE EDITING MARKET: SERVICE FOOTPRINT
  • TABLE 554 GENE EDITING MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 555 GENE EDITING MARKET: APPLICATION FOOTPRINT
  • TABLE 556 GENE EDITING MARKET: REGION FOOTPRINT
  • TABLE 557 GENE EDITING MARKET: KEY STARTUPS/SMES
  • TABLE 558 GENE EDITING MARKET: COMPETITIVE BENCHMARKING OF KEY START UPS/SMES
  • TABLE 559 GENE EDITING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 560 GENE EDITING MARKET: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 561 GENE EDITING MARKET: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 562 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 563 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 564 THERMO FISHER SCIENTIFIC INC.: PRODUCT APPROVALS/LAUNCHES, JANUARY 2021−SEPTEMBER 2024
  • TABLE 565 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 566 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 567 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 568 MERCK KGAA.: PRODUCTS/SERVICES OFFERED
  • TABLE 569 MERCK KGAA: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 570 GENSCRIPT: COMPANY OVERVIEW
  • TABLE 571 GENSCRIPT.: PRODUCTS/SERVICES OFFERED
  • TABLE 572 GENSCRIPT: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 573 GENSCRIPT: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 574 GENSCRIPT: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 575 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 576 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 577 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 578 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 579 REVVITY. INC. COMPANY OVERVIEW
  • TABLE 580 REVVITY, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 581 REVIVTY, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 582 REVVITY, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 583 LONZA: COMPANY OVERVIEW
  • TABLE 584 LONZA: PRODUCTS/SERVICES OFFERED
  • TABLE 585 LONZA: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 586 TECAN TRADING AG: COMPANY OVERVIEW
  • TABLE 587 TECAN TRADING AG: PRODUCTS/SERVICES OFFERED
  • TABLE 588 TECAN TRADING AG: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 589 SANGAMO THERAPEUTICS: COMPANY OVERVIEW
  • TABLE 590 SANGAMO THERAPEUTICS: PRODUCTS/SERVICES OFFERED
  • TABLE 591 SANGAMO THERAPEUTICS: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 592 PRECISION BIOSCIENCES: COMPANY OVERVIEW
  • TABLE 593 PRECISION BIOSCIENCES: PRODUCTS/SERVICES OFFERED
  • TABLE 594 PRECISION BIOSCIENCES: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 595 CELLECTIS S.A.: COMPANY OVERVIEW
  • TABLE 596 CELLECTIS S.A.: PRODUCTS/SERVICES OFFERED
  • TABLE 597 CELLECTIS S.A.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 598 REGENERON PHARMACEUTICALS, INC.: COMPANY OVERVIEW
  • TABLE 599 REGENERON PHARMACEUTICALS INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 600 REGENERON PHARMACEUTICALS, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 601 AMSBIO: COMPANY OVERVIEW
  • TABLE 602 AMSBIO: PRODUCTS/SERVICES OFFERED
  • TABLE 603 CREATIVE BIOGENE: COMPANY OVERVIEW
  • TABLE 604 CREATIVE BIOGENE: PRODUCTS/SERVICES OFFERED
  • TABLE 605 SYNTHEGO: COMPANY OVERVIEW
  • TABLE 606 SYNTHEGO: PRODUCTS/SERVICES OFFERED
  • TABLE 607 SYNTHEGO: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 608 SYNTHEGO: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 609 SYNTHEGO: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 610 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 611 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 612 TAKARA BIO INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 613 TAKARA BIO, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 614 BIO-TECHNE: COMPANY OVERVIEW
  • TABLE 615 BIO-TECHNE.: PRODUCTS/SERVICES OFFERED
  • TABLE 616 BIO-TECHNE: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 617 BIO-TECHNE: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 618 CARIBOU BIOSCIENCES, INC.: COMPANY OVERVIEW
  • TABLE 619 CARIBOU BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 620 CARIBOU BIOSCIENCES, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 621 BIONEER CORPORATION: COMPANY OVERVIEW
  • TABLE 622 BIONEER CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 623 REPROCELL, INC.: COMPANY OVERVIEW
  • TABLE 624 REPROCELL, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 625 ALSTEM INC.: COMPANY OVERVIEW
  • TABLE 626 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
  • TABLE 627 INSCRIPTA, INC.: COMPANY OVERVIEW
  • TABLE 628 BIOCAT GMBH: COMPANY OVERVIEW
  • TABLE 629 INTEGRATED DNA TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 630 COBO TECHNOLOGIES APS.: COMPANY OVERVIEW
  • TABLE 631 GENECOPOEIA, INC.: COMPANY OVERVIEW
  • TABLE 632 HERA BIOLABS: COMPANY OVERVIEW
  • TABLE 633 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 634 AXOL BIOSCIENCE LTD.: COMPANY OVERVIEW
  • TABLE 635 CELLECTA, INC.: COMPANY OVERVIEW
  • TABLE 636 APPLIED STEMCELL: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 GENE EDITING MARKET: BREAKDOWN OF PRIMARIES
  • FIGURE 3 GENE EDITING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
  • FIGURE 5 ILLUSTRATIVE EXAMPLE OF AGILENT TECHNOLOGIES, INC.: REVENUE SHARE ANALYSIS (2023)
  • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 8 GENE EDITING MARKET: CAGR PROJECTIONS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 GENE EDITING MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 GENE EDITING PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 GENE EDITING PRODUCTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 GENE EDITING SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 GENE EDITING SERVICES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 GENE EDITING SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 GEOGRAPHIC SNAPSHOT OF GENE EDITING MARKET
  • FIGURE 19 INCREASING DEMAND FOR PERSONALIZED MEDICINE AND EXPANDING APPLICATIONS OF GENE EDITING TO DRIVE MARKET
  • FIGURE 20 REAGENTS & CONSUMABLES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN US IN 2023
  • FIGURE 21 CELL LINE ENGINEERING TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 22 GENE EDITING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 GOVERNMENT FUNDING FOR GENE EDITING PROJECTS, 2019−2023 (USD MILLION)
  • FIGURE 24 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 25 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY CONSUMABLES (2023)
  • FIGURE 26 AVERAGE SELLING PRICE TREND OF SERVICES, BY TYPE
  • FIGURE 27 AVERAGE SELLING PRICE, BY REGION, 2023 (USD)
  • FIGURE 28 GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 GENE EDITING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 GENE EDITING MARKET: TRANSFECTION & SCREENING TO ADD MAXIMUM VALUE TO WORKFLOW
  • FIGURE 31 GENE EDITING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 32 IMPACT OF AI/GEN AI IN GENE EDITING MARKET
  • FIGURE 33 PATENT APPLICATIONS FOR GENE EDITING (JANUARY 2013–DECEMBER 2023)
  • FIGURE 34 GENE EDITING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 36 KEY BUYING CRITERIA OF END USERS, BY PRODUCT
  • FIGURE 37 KEY BUYING CRITERIA OF END USERS, BY SERVICES
  • FIGURE 38 NIH FUNDING FOR GENE EDITING PROJECTS
  • FIGURE 39 NORTH AMERICA: GENE EDITING MARKET SNAPSHOT
  • FIGURE 40 ASIA PACIFIC: GENE EDITING MARKET SNAPSHOT
  • FIGURE 41 GENE EDITING MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019−2023
  • FIGURE 42 MARKET SHARE ANALYSIS OF GENE EDITING MARKET, 2023
  • FIGURE 43 RANKING OF KEY PLAYERS IN GENE EDITING MARKET, 2023
  • FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 45 EV/EBITDA OF KEY PLAYERS
  • FIGURE 46 GENE EDITING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 47 GENE EDITING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 48 GENE EDITING MARKET: COMPANY FOOTPRINT
  • FIGURE 49 GENE EDITING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 50 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 51 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 52 GENSCRIPT: COMPANY SNAPSHOT (2023)
  • FIGURE 53 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 54 REVVITY, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 55 LONZA: COMPANY SNAPSHOT (2023)
  • FIGURE 56 TECAN TRADING AG: COMPANY SNAPSHOT (2023)
  • FIGURE 57 SANGAMO THERAPEUTICS: COMPANY SNAPSHOT (2023)
  • FIGURE 58 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2023)
  • FIGURE 59 CELLECTIS S.A.: COMPANY SNAPSHOT (2023)
  • FIGURE 60 REGENERON PHARMACEUTICALS INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 61 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 62 BIO-TECHNE: COMPANY SNAPSHOT (2023)
  • FIGURE 63 CARIBOU BIOSCIENCES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 64 BIONEER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 65 REPROCELL, INC.: COMPANY SNAPSHOT (2023)

This study on the gene editing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the gene editing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as the International Chromosome and Genome Society (ICGS), the National Human Genome Research Institute (NHGRI), the Asia Pacific Society of Human Genetics (APSHG), the Genetics Society of America (GSA), the European Society of Human Genetics (ESHG), Centers for Common Disease Genomics (CDDG), Centre for Cellular & Molecular Biology (CCMB) (India), and the Department of Biotechnology (DBT) (India). Secondary sources include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global gene editing market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global gene editing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing gene editing products and services; experts from the demand side, such as personnel from pharmaceutical & biotechnology companies, Academic & research institutes, and CROs & CDMOs. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the gene editing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research.
  • The revenues generated from the gene editing market business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Data Triangulation

To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

The gene editing market, as covered within the scope of this report, includes products, technologies, and services that facilitate genetic modifications across various applications. This encompasses reagents and consumables, as well as software and systems for planning, executing, and analyzing gene editing processes. Additionally, the report covers services that utilize gene editing technologies like CRISPR, TALEN, ZFN, and other methods such as Meganucleases, PiggyBac, and Prime Editing, applied in areas like cell line engineering, genome editing, drug discovery, clinical diagnostics, and xenotransplantation. These components serve end users, including pharmaceutical and biotechnology companies involved in therapeutic development, as well as academic and research institutes focused on scientific research.

Stakeholders

  • Manufacturers and distributors of gene editing products and services
  • Pharmaceutical and biotechnology companies
  • Market research and consulting firms
  • R&D centers
  • Researchers and scientists
  • Academic & research institutes
  • CDMOs & CROs
  • Biobanks
  • Diagnostic companies.

Report Objectives

  • To define, describe, segment, and forecast the gene editing market based on offerings, product type, product application, product technology, reagent & consumables technique, product end user, service type, service application, service end user and region
  • To provide detailed information about the factors influencing market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall gene editing market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments concerning six main regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa.
  • To strategically profile the key players in the global gene editing market and comprehensively analyze their core competencies2 and market rankings.
  • To track and analyze competitive developments, such as product launches, acquisitions, collaborations, expansions, and partnerships in the gene editing market.
  • To profile the key players in the global gene editing market and comprehensively analyze their instruments, reagents, kits, consumables, and services portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the gene editing market
  • To benchmark players within the gene editing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

Previous Versions of this Report

Genome Editing Market Growth by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user (Pharmaceutical, Biotechnology, Academia) - Global Forecast to 2026

Report Code BT 3380
Published in Jul, 2023, By MarketsandMarkets™

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user (Pharmaceutical, Biotechnology, Academia) - Global Forecast to 2026

Report Code BT 3380
Published in Nov, 2021, By MarketsandMarkets™

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025

Report Code BT 3380
Published in Jun, 2020, By MarketsandMarkets™

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs) - Global Forecast 2022

Report Code BT 3380
Published in Nov, 2017, By MarketsandMarkets™

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021

Report Code BT 3380
Published in Oct, 2016, By MarketsandMarkets™

Genome Editing / Genome Engineering Market by Application (Cell Line Engineering, Animal & Plant Genetic Engineering), Technology (CRISPR, Antisense, TALEN, Zinc Finger Nuclease) & End User (Biotechnology & Pharmaceutical, CRO) - Global Forecast to 2019

Report Code BT 3380
Published in Apr, 2015, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.

By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Gene Editing Market

+1-888600-6441

Corporate Office Hours

+1-888600-6441

US/Can Toll Free

+44-800-368-9399

UK Office Hours

©2024 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status